Both in Biotechnology
Relay Therapeutics vs CRISPR Therapeutics AG
Over the past year RLAY returned +151.3% and CRSP returned −19.3%; their daily moves had a correlation of 0.32.
RLAY +151.3% CRSP −19.3%Growth of $1, one year, split-adjusted
| Metric | RLAY | CRSP |
|---|---|---|
| Price | $17.44 | $49.99 |
| Market cap | $3.82B | $4.83B |
| Today | +0.93% | 0.00% |
| 1 month | −10.1% | −12.8% |
| 6 months | +34.2% | −4.6% |
| Year to date | +106.1% | −4.7% |
| 1 year | +144.3% | −21.9% |
| Revenue growth (YoY) | −48.3% | +1325.1% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −23916.3% | −879.6% |
| P/E (TTM) | — | — |
| Price / sales | 369.3× | 192.0× |
| Net cash | $910.9M | $1.69B |
| Dividend yield | — | — |
| Volatility (60d) | 48.7% | 53.1% |
| Short % of float | 27.9% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).